Shinpoong Pharmaceutical Co Ltd
KRX:019170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shinpoong Pharmaceutical Co Ltd
KRX:019170
|
KR |
|
S
|
Sekonix Co Ltd
KOSDAQ:053450
|
KR |
|
B
|
Banco Santander SA
XHAM:BSD2
|
ES |
|
Palo Alto Networks Inc
BMV:PANW
|
US |
|
D
|
Delek US Holdings Inc
F:DEH
|
US |
|
United States Lime & Minerals Inc
F:ULI
|
US |
|
Ucb SA
XBRU:UCB
|
BE |
|
U
|
Unite Group PLC
XMUN:U1B
|
UK |
|
Evoke PLC
LSE:EVOK
|
GI |
|
G
|
GO Element Co Ltd
KOSDAQ:311320
|
KR |
|
C
|
China International Capital Corp Ltd
F:CIM
|
CN |
|
C
|
Cintas Corp
F:CIT
|
US |
|
D
|
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
|
ID |
|
T
|
Tractor Supply Co
F:TR4
|
US |
Bankruptcy Probability
Shinpoong Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shinpoong Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
Shinpoong Pharmaceutical Co Ltd
KRX:019170
|
485B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
637.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
358.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
341.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.6B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
312.6B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
162.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shinpoong Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shinpoong Pharmaceutical Co Ltd has total debt of 50.4B KRW. This includes both short-term (39.2B KRW) and long-term (11.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.